Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. [electronic resource]
Producer: 20070726Description: 5318-27 p. digitalISSN:- 0008-5472
- Acetylation
- Antigens, Nuclear -- metabolism
- Antineoplastic Agents -- pharmacology
- DNA Breaks, Double-Stranded
- DNA Repair -- drug effects
- DNA, Neoplasm -- drug effects
- DNA-Binding Proteins -- metabolism
- Drug Synergism
- Enzyme Inhibitors -- pharmacology
- Histone Deacetylase Inhibitors
- Humans
- Ku Autoantigen
- Male
- Models, Molecular
- Prostatic Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.